Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00300

Submission Number:
00300
Commenter:
Matthew Menz
State:
Florida
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
The Aetna merger with Caremark I believe will create a competitive imbalance in the industry. CVS will hold too large of a market share with insurance and will allow them to pretty much write the rule book, fix prices and reimbursement in their favor. Cvs is already one of the only PBMs that restricts Pharmacy access and drives their customers into CVS stores. I've also noticed a sharp decline in reimbursements when other plans have been taken over by CVS, such as Wellcare and Ambetter. These under payments are significant and are not reflected uniformly across the industry. It seems the goal is to put the independent Pharmacy out of business and force people to CVS stores. I believe the government should get involved because this is a violation of antitrust laws